Iterum Therapeutics plc (ITRMF) EBT Margin (2017 - 2025)
Iterum Therapeutics (ITRMF) posted quarterly EBT Margin of 2268.46% for Q3 2025, up 95.89% quarter-over-quarter from 55259.46% in Q1 2019.
Iterum Therapeutics plc (ITRMF) EBT Margin (2017 - 2025) Analysis & Trends
Iterum Therapeutics' EBT Margin history runs 4 years deep, the most recent figure standing at 2268.46% for Q3 2025.
- In Q3 2025, EBT Margin changed N/A year-over-year to 2268.46%; the TTM figure through Sep 2025 stood at 456.67% (changed N/A YoY), while the FY2019 annual figure was 277529.73%, down 26871684.0% from the prior year.
- EBT Margin for Q3 2025 stood at 2268.46%, up from 55259.46% in the prior quarter.
- The five-year high for EBT Margin was 2268.46% in Q3 2025, with the low at 2268.46% in Q3 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -2,268.46% |
| Mar 31, 2019 | -55,259.46% |
| Dec 31, 2018 | -10,063.18% |
| Sep 30, 2018 | -9,762.20% |
| Jun 30, 2018 | -8,475.14% |
| Mar 31, 2018 | -6,312.57% |
| Dec 31, 2017 | -2,597.99% |
| Sep 30, 2017 | -5,083.65% |